Product Information
CEFIXIME 100 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $2.4219 per ML under NDC 65862075150. Its NADAC has been published 278 times since Oct 21, 2015.
FDA first approved this application on Apr 14, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862075150
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA204835FDA Approved
4/14/2015
TE Code
AB
On Market Since
4/14/2015
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 100 MG/5 ML SUSP has been published 278 times since Oct 21, 2015, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4219 per ML |
|---|---|
| All-time high | $3.3767 (Dec 16, 2015) |
| All-time low | $2.0732 (Aug 21, 2024) |
| 52-week high | $2.4219 |
| 52-week low | $2.1725 |
| Median price | $2.8771 |
| Average price | $2.6860 |
| Largest weekly change | -21.6% (May 22, 2024) |
| Weeks tracked | 278 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cefixime market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFIXIME 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 100 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $2.4219 per ML (NDC 65862075150), effective Aug 19, 2026.
How has the price of CEFIXIME 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFIXIME 100 MG/5 ML SUSP has declined 24.5%. It has been tracked across 278 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for CEFIXIME 100 MG/5 ML SUSP?
Since Oct 21, 2015, the NADAC for CEFIXIME 100 MG/5 ML SUSP has ranged from a low of $2.0732 (Aug 21, 2024) to a high of $3.3767 (Dec 16, 2015), with a median of $2.8771 per ML.
Are there cheaper alternatives to CEFIXIME 100 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of CEFIXIME 100 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEFIXIME 100 MG/5 ML SUSP?
CEFIXIME 100 MG/5 ML SUSP (NDC 65862075150) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.